Earnings FeedTerminal

⌘K

Home/Filings/8-K/0001328143-20-000034

8-K//Current report

Adamas Pharmaceuticals Inc 8-K

Accession 0001328143-20-000034

CIK 0001328143operating

View on SEC.gov Company Profile

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 4:01 PM ET

Size

56.8 KB

Accession

0001328143-20-000034

Documents

1 file

8-K
proxyvote2020item507.htmPrimary
8-K

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001328143

Filing Metadata

Form type: 8-K
Filed: Jun 4, 8:00 PM ET
Accepted: Jun 5, 4:01 PM ET
Size: 56.8 KB

View on SEC.gov